CKPT Checkpoint Therapeutics
- 2.220
- +0.040+1.83%
- 2.230
- +0.010+0.45%
Checkpoint Therapeutics News
Checkpoint Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(9.8%)
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
Checkpoint Therapeutics | D: Filing D
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Oliviero James F III
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAY WILLIAM GARRETT
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAY WILLIAM GARRETT
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Oliviero James F III
Checkpoint Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
Checkpoint Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(11.2%)
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WEISS MICHAEL S
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Amit Sharma
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SALZMAN BARRY M
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROSENWALD LINDSAY A MD
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Herskowitz Neil
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bechon Christian
Checkpoint Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(7.5%)
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
Checkpoint Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Amit Sharma
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Oliviero James F III
Checkpoint Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GRAY WILLIAM GARRETT
Analysis
Price Target
No Data
No Data